Health Policy

Regional Variation in Total Cost per Radical Prostatectomy in the Healthcare Cost and Utilization Project Nationwide Inpatient Sample Database

Makarov, D.V., S. Loeb, A.B. Landman, M.E. Nielsen, C.P. Gross, D.L. Leslie, D.F. Penson, and R.A. Desai Read more

Validation of the Partin Nomogram for Prostate Cancer in a National Sample

Yu, J.B., D.V. Makarov, R. Sharma, R.E. Peschel, A.W. Partin, and C.P. Gross Read more

DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme

Isharwal, S., D.V. Makarov, H.B. Carter,J.I. Epstein, A.W. Partin, P. Landis, C. Marlow, and R.W. Veltri Read more

Patient Centered Outcomes in Prostate Cancer Treatment: Predictors of Satisfaction Up to 2 Years After Open Radical Retropubic Prostatectomy

Abraham, N.E., D.V. Makarov, J. Laze, E. Stefanovics, R. Desai, and H. Lepor, Herbert Read more

Renal Ultrasonography in the Evaluation of Acute Kidney Injury: Developing a Risk Stratification Framework

Licurse, A., M.C. Kim, J. Dziura, H.P. Forman, R.N. Formica, D.V. Makarov, C.R. Parikh, and C.P. Gross Read more

Significance of preoperative PSA velocity in men with low serum PSA and normal DRE

Makarov, D.V., S. Loeb, A. Magheli, K. Zhao, E. Humphreys, M.L. Gonzalgo, A.W. Partin, and M. Han Read more

ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program

Isharwal, S., D.V. Makarov, L.J. Sokoll, P. Landis, C. Marlow, J.I. Epstein, A.W. Partin, H.B. Carter, and R.W. Veltri Read more

Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score

Huang, Y., S. Isharwal, A. Haese, F.K.H. Chun,D.V. Makarov, Z. Feng, M. Han, E. Humphreys, J.I. Epstein, A.W. Partin, and R.W. Veltri Read more

A New Formula for Prostate Cancer Lymph Node Risk

Yu, J.B. D.V. Makarov, and C. Gross Read more

Robotic Surgery Claims on United States Hospital Websites

Jin, L.X., A.M. Ibrahim, N.A. Newman, D.V. Makarov, P.J. Pronovost, and M.A. Makary Read more

The Population Level Prevalence and Correlates of Appropriate and Inappropriate Imaging to Stage Incident Prostate Cancer in the Medicare Population

Makarov, D.V., R.A. Desai, J.B. Yu, R. Sharma, N. Abraham, P.C. Albertsen, D.F. Penson, and C.P. Gross Read more

The Relationship Between Clinical Benefit and Receipt of Curative Therapy for Prostate Cancer

Raldow, A.C., C.J. Presley, J.B. Yu, R. Sharma, L.D. Cramer, P.R. Soulos, J.B. Long, D.V. Makarov, and C.P. Gross Read more
Subscribe to Health Policy